Ειδήσεις: VIR BIOTECHNOLOGY | PXAI

10/04 16:51 yahoo.com

Vir Biotechnology (VIR) Leading with Its BiTEs Therapy

Vir Biotechnology BiTE therapy T‑cell engager immunotherapy cancer treatment targeted therapy

09/04 10:03 defenseworld.net

Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR

Aberdeen Group Vir Biotechnology hedge funds ARCH Venture Management Millennium Management share sale

09/04 10:03 defenseworld.net

Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR

Aberdeen Group Vir Biotechnology hedge funds ARCH Venture Management Millennium Management share sale

Loading...